Table 2

Glucocorticoid properties

TAT2-aGlycogen2-bGR2-cCBG2-c
ALDO1.1  ± 0.11.5  ± 0.274.6  ± 7.6905.5  ± 50.1
DOC2.8  ± 0.33.1  ± 0.66.9  ± 2.114.8  ± 3.5
CORT7.4  ± 0.65.7  ± 0.51.0  ± 0.21.0  ± 0.1
PROG2.0  ± 0.50.9  ± 0.16.2  ± 0.5289.1  ± 9.9
11-OP1.0  ± 0.11.4  ± 0.2>2000>2000
6-OP1.0  ± 0.10.8  ± 0.3>2000>2000
  • 2-a Isolated hepatocytes from ADX rats were incubated with 100 nM steroid, and the induction of tyrosine amino transferase (TAT) activity was measured. Results represent fold induction (mean ± S.E. of three experiments performed in duplicate) with respect to the control incubated with vehicle alone (4.0 ± 1.0 μmol of tyrosine × 10−6 cells × min−1).

  • 2-b Glycogen was obtained from the liver of ADX rats after acute treatment with the indicated steroid. Values are expressed as a fold increase (mean ± S.E. for eight rats per group) with respect to controls injected with vehicle (9.1 ± 1.2 mg of glycogen/g of liver).

  • 2-c RBAs were calculated from competition curves between the steroid and 5.0 nM [3H]CORT. Thymocyte cytosol homogenized in TEGI buffer was used as a source of GR. Rat plasma was fractionated with solid ammonium sulfate at 30 to 60% of saturation, dissolved in TEGI buffer afterward, dialyzed, and used as a source of albumin-free CBG. Values are expressed in nanomolar and represent the mean ± S.E. of three independent experiments, each one performed in quintuplicate.